CXCL8 and neoplasm: In patients treated with NAC-ICI, tumor IL-8 signature was associated with the eMDSC immune population in the peripheral blood (FDR-corrected p = 0.007; Supplementary Fig. 6A-B) and with MDSC signature37 in the tumor (Supplementary Fig. 6C).